Zum Hauptinhalt springen

Affinity Biotech

affinity

Founded in 2006, Affinity Biosciences is a pioneering Life Science and High-Tech company whose biochemical products and services are mainly applied in biotechnology, medical research and pharmaceutical development.

Dedicating to advancing customer success through innovation, Affinity Biosciences has established R&D affiliates in the United Kingdom and United States with the aim of providing outstanding service around the globe.Our customers include scientists and technologists in life science companies, university and government institutions, hospitals and industry. To underline our commitment to our customers and enhance our standards of service, we have opened packaging and quality control facilities in the People’s Republic of China. Our goal is to develop high-quality antibody that focuses on Cell Signaling Transduction research, including Akt,AMPK,NF-KappaB,TGF-beta,etc,as well as inhibitors and related reagents.

www.affbiotech.com

The prices are on request! Contact Us by e-mail info@divbio.de

Heterophilic antibody blocker for ELISA assays utilizing mouse assay antibodies-1250 µg BL-002-1250



Der In den Warenkorb Knopf erscheint sobald die obigen Werte ausgewählt wurden

Spezifikationen

1250 µg
BL-002-1250 contains a proprietary mixture of proteins and buffer reagents designed to reduce heterophilic interactions in ELISA assays utilizing mouse immunoreagents.

One vial of BL-002-1250 contains 1250 μg IgG which is sufficient as sample diluent additive for one 96-well plate if used at 50 μg/mL. Optimal blocker concentration needs to be validated by the end-user for accurate results.